Table 3.
AUCs for Insulin Resistance Surrogates in Relation to NAFLD
| Variables | AUC (95% CI) | Specificity | Sensitivity | Youden |
|---|---|---|---|---|
| TyG-BMI+ other factors | 0.8059 (0.8025,0.8094) | 0.704796 | 0.756200 | 0.460996 |
| METS-IR+ other factors | 0.7959 (0.7923,0.7994) | 0.667824 | 0.775822 | 0.443645 |
| HSI+ other factors | 0.7763 (0.7726,0.78) | 0.664353 | 0.747534 | 0.411886 |
| LAP+ other factors | 0.7313 (0.7272,0.7354) | 0.646813 | 0.697335 | 0.344148 |
| TyG + other factors | 0.6901 (0.6857,0.6944) | 0.594807 | 0.687742 | 0.282549 |
| TG/HDL-c+ other factors | 0.6781 (0.6737,0.6825) | 0.647463 | 0.610236 | 0.257699 |
| VAI+ other factors | 0.6742 (0.6697,0.6786) | 0.633617 | 0.621682 | 0.255299 |
Notes: Other factors: age, sex, marital status, smoking, physical exercise, SBP, RHR.
Abbreviations: AUC, area under the curve; NAFLD, Non-alcoholic fatty liver disease; IR, Insulin Resistance; TyG, triglyceride-glucose index; TyG-BMI, TyG index with body mass index; LAP, lipid accumulation product; VAI, visceral adiposity index; TG/HDL-c, triglycerides/high-density lipoprotein cholesterol ratio; METS-IR, metabolic score for IR; HSI, hepatic steatosis index; SBP, systolic blood pressure; RHR, resting heart rate.